Sale!

PDGFR Mutation Screening Exons 12, 14, 18

Original price was: $400.Current price is: $300.

-25%

The PDGFR Mutation Screening for Exons 12, 14, and 18 is a specialized genetic test that analyzes specific regions of the PDGFR gene for mutations associated with various cancers. This comprehensive screening helps identify genetic alterations that can guide targeted therapy decisions and personalized treatment approaches. Using advanced Sanger Sequencing technology, the test provides accurate detection of mutations in tumor tissue samples. Results are typically available within 7-8 days, offering valuable insights for oncologists and patients. The test is priced at $300 USD (discounted from $400 USD) and requires a doctor’s prescription for most cases. This screening is particularly important for individuals with suspected genetic cancer syndromes or those requiring targeted therapy planning.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

PDGFR Mutation Screening Exons 12, 14, 18

Comprehensive Genetic Cancer Testing for Personalized Treatment

The PDGFR Mutation Screening for Exons 12, 14, and 18 represents a cutting-edge approach to genetic cancer diagnostics. This specialized test focuses on analyzing specific regions of the Platelet-Derived Growth Factor Receptor (PDGFR) gene, which plays a crucial role in cell growth, division, and survival. Mutations in these exons can lead to uncontrolled cell proliferation and are associated with various malignancies, making this screening essential for modern oncology practice.

What Does This Test Measure and Detect?

This advanced genetic screening specifically targets:

  • Exon 12 mutations associated with gastrointestinal stromal tumors (GIST)
  • Exon 14 alterations linked to various solid tumors
  • Exon 18 mutations, particularly relevant for lung cancers and other malignancies
  • Point mutations, insertions, and deletions within these critical gene regions
  • Genetic variations that may respond to targeted tyrosine kinase inhibitors

Using sophisticated Sanger Sequencing technology, the test provides high-resolution analysis of tumor tissue samples, ensuring accurate detection of even subtle genetic changes that could impact treatment decisions.

Who Should Consider This Genetic Screening?

This test is particularly recommended for individuals experiencing:

  • Diagnosed gastrointestinal stromal tumors (GIST) requiring treatment planning
  • Suspected genetic cancer syndromes with family history
  • Resistance to standard cancer therapies
  • Need for targeted therapy selection
  • Unexplained tumor growth patterns
  • Planning for personalized cancer treatment approaches

Key Benefits of PDGFR Mutation Screening

Undergoing this comprehensive genetic analysis offers numerous advantages:

  • Personalized Treatment Planning: Results guide selection of appropriate targeted therapies
  • Improved Prognostic Information: Helps predict disease progression and treatment response
  • Enhanced Therapeutic Outcomes: Increases likelihood of successful treatment with fewer side effects
  • Family Risk Assessment: Provides insights into potential hereditary cancer risks
  • Cost-Effective Care: Helps avoid ineffective treatments and associated expenses

Understanding Your Test Results

Your PDGFR Mutation Screening results will be carefully interpreted by our genetic specialists:

  • Positive Result: Indicates the presence of specific mutations that may respond to targeted therapies
  • Negative Result: Suggests absence of tested mutations, potentially indicating need for alternative treatment approaches
  • Variant of Uncertain Significance: Some genetic changes may require additional clinical correlation
  • Comprehensive Report: Includes detailed interpretation and clinical recommendations

All results are accompanied by expert consultation to ensure proper understanding and appropriate next steps.

Test Pricing and Details

Test Component Price (USD)
Discount Price $300
Regular Price $400
Turnaround Time 7-8 days
Sample Type Tumor Tissue (Paraffin Embedded Blocks)
Testing Method Sanger Sequencing

Nationwide Accessibility

We proudly serve patients across the United States with convenient testing locations in all major cities including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network of certified laboratories ensures consistent, high-quality testing standards nationwide.

Important Pre-Test Information

Please note that PDGFR Mutation Screening requires a doctor’s prescription for most cases. Prescription requirements do not apply to surgery and pregnancy cases or individuals planning international travel. Our team is available to assist with any prescription-related questions or concerns.

Take the Next Step Toward Personalized Cancer Care

Don’t leave your treatment decisions to chance. Our PDGFR Mutation Screening provides the genetic insights needed for informed, personalized cancer care. With rapid 7-8 day turnaround and comprehensive analysis, you’ll have the information necessary to work with your healthcare team on the most effective treatment strategy.

Ready to schedule your test? Contact us today at +1(267) 388-9828 or book your appointment online. Our genetic specialists are standing by to answer your questions and guide you through the testing process.